Inspiratory flow rates and volumes with the Aerolizer dry powder inhaler in asthmatic children and adults
- 1 January 2004
- journal article
- research article
- Published by Taylor & Francis in Current Medical Research and Opinion
- Vol. 20 (2) , 131-137
- https://doi.org/10.1185/030079903125002793
Abstract
Objective: To assess the peak inspiratory flow rate (PIFR) and forced inspiratory vital capacity (FIVC) through the formoterol (Foradil ) Aerolizer* in patients with mild, moderate and severe asthma. Research design and methods: PIFR and FIVC were assessed in 33 adults and 32 children using a spirometer alone (baseline), a spirometer with an adaptor, and a spirometer with an adaptor and the Aerolizer inhaler (placebo loaded). Results: Of adult patients using the Aerolizer inhaler, 73% had PIFR values of >100l/min and 91% had values of >60l/min. PIFR in adults was reduced from a mean baseline of 283l/min to 118l/min through the loaded Aerolizer inhaler. Similarly, 75% of children using the Aerolizer inhaler had PIFR values >80l/min and 91% had values of >60l/min. The mean PIFR in children was reduced from a baseline of 154l/min to 100l/min through the loaded Aerolizer inhaler. Only small mean decreases from baseline were observed in FIVC through the loaded Aerolizer inhaler: 8.4% in adults and 3.8% in children. FIVC values of >2.0 litre were achieved in 82% of adults, and 81% of children achieved FIVC values of >1.5 litre. Conclusion: This study, albeit in a relatively small patient population, suggests that most children and adults with asthma can generate PIFRs of >60l/min and FIVCs of >1.5litre through the Aerolizer inhaler regardless of their disease severity. Such findings compare extremely favourably with other dry powder inhalers.Keywords
This publication has 12 references indexed in Scilit:
- The inhalers of the future? A review of dry powder devices on the market todayPulmonary Pharmacology & Therapeutics, 2003
- Evolution of dry powder inhaler design, formulation, and performanceRespiratory Medicine, 2002
- In Vitro Aerosol Performance and Dose Uniformity between the Foradile® Aerolizer® and the Oxis® Turbuhaler®Journal of Aerosol Medicine, 2001
- Rationale for the Choice of an Aerosol Delivery SystemJournal of Aerosol Medicine, 2000
- Inspiratory Flow Rates through a Novel Dry Powder Inhaler (Clickhaler) in Pediatric Patients with AsthmaJournal of Aerosol Medicine, 1999
- Flow-dependent effect of formoterol dry-powder inhaled from the AerolizerEuropean Respiratory Journal, 1997
- Inspiratory muscle strength and endurance in steroid-dependent asthma.American Journal of Respiratory and Critical Care Medicine, 1996
- Peak inspiratory flow through Turbuhaler in acute asthmaEuropean Respiratory Journal, 1995
- The Relationship Between Powder Inhaler Resistance and Peak Inspiratory Conditions in Healthy Volunteers — Implications for In Vitro TestingJournal of Aerosol Medicine, 1993
- Strength and Endurance of Inspiratory, Expiratory, and Limb Muscles in Asthma1–3American Review of Respiratory Disease, 1986